Pancreatic Cancer Research

ResearcherNational Cancer InstituteActive in the last 2 years

Agnès Basseville

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9349-1819; OpenAlex author ID A5048381191. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.drup.2025.101312↗
  2. Targeting KRAS and the vitamin D receptor via microtubules Co-author DOI 10.1038/nrclinonc.2015.125↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Susan Elaine Bates · 2 shared papers, 2015–2026 · strength 0.32
  2. Tito Fojo · 2 shared papers, 2015–2026 · strength 0.32
  3. Ravikanth Maddipati · 1 shared paper, 2026 · strength 0.23
  4. Maryam Safari · 1 shared paper, 2026 · strength 0.23
  5. Kenneth P. Olive · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.